Glucose-Lowering Drugs with Proven Cardiovascular Benefit Following Acute Coronary Syndrome in Patients with Type 2 Diabetes: Treatment Gaps and Outcomes

Ibrahim Naoum,Walid Saliba,Ofra Barnett-Griness,Amir Aker,Barak Zafrir

European Heart Journal（2024）

Cited 0|Views2
No score
Key words
type 2 diabetes mellitus,SGLT2 inhibitors,GLP1 receptor agonists,acute coronary syndrome,real world,drug prescriptions
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined